Stockscreener 앱 받기
3.63
3.97%
-0.15
전일 마감가:
$3.78
열려 있는:
$3.79
하루 거래량:
350.16K
Relative Volume:
0.62
시가총액:
$222.80M
수익:
-
순이익/손실:
$-73.79M
주가수익비율:
-1.2782
EPS:
-2.84
순현금흐름:
$-77.44M
1주 성능:
+1.11%
1개월 성능:
+8.04%
6개월 성능:
-29.10%
1년 성능:
+72.04%
1일 변동 폭
$3.59
$3.79
1주일 범위:
$3.50
$3.89
52주 변동 폭
$1.35
$6.85
Pyxis Oncology Inc Stock (PYXS) Company Profile
명칭
Pyxis Oncology Inc
전화
(617) 221-9059
주소
321 HARRISON AVENUE, BOSTON
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-11-02 | 개시 | BofA Securities | Neutral |
| 2021-11-02 | 개시 | Credit Suisse | Outperform |
| 2021-11-02 | 개시 | Jefferies | Buy |
Pyxis Oncology Inc 주식(PYXS)의 최신 뉴스
Moment Of Truth Approaches For Pyxis Oncology (NASDAQ:PYXS) - Seeking Alpha
Pyxis Oncology : Morgan Stanley 22nd Annual Global Healthcare Conference - Marketscreener.com
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Pyxis Oncology Inc (PYXS) looking to reclaim success with recent performance - SETE News
Have you been able to find a good deal on Pyxis Oncology Inc’s shares? - US Post News
Quarterly Snapshot: Quick and Current Ratios for Pyxis Oncology Inc (PYXS) - The Dwinnex
Pyxis Oncology to Participate in Two Upcoming Investor Conferences - GlobeNewswire
Pyxis Oncology to Participate in Two Upcoming Investor Conferences - StockTitan
JAZZ: 3 Oncology Stocks With Major Upside - StockNews.com
PYXS Stock Earnings: Pyxis Oncology Misses EPS for Q2 2024 - MSN
Market Momentum Report: Pyxis Oncology Inc (PYXS)’s Positive Close at 3.62 - The Dwinnex
Q3 2024 EPS Estimates for Pyxis Oncology, Inc. Boosted by William Blair (NASDAQ:PYXS) - MarketBeat
What is the investor’s view on Pyxis Oncology Inc (PYXS)? - US Post News
Cetera Advisors LLC Makes New $100,000 Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Q3 2024 Earnings Estimate for Pyxis Oncology, Inc. (NASDAQ:PYXS) Issued By William Blair - Defense World
Vanguard Group Inc. Acquires 94,740 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology's (PYXS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Pyxis Oncology maintains steady target with Buy rating from H.C. Wainwright - Investing.com India
Pyxis Oncology maintains steady target with Buy rating from H.C. Wainwright - Investing.com
Market Insight: Pyxis Oncology Inc (PYXS)’s Notable Gain, Closing at 3.43 - The Dwinnex
Pyxis Oncology (NASDAQ:PYXS) Earns “Buy” Rating from HC Wainwright - Defense World
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - GlobeNewswire
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - Marketscreener.com
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - StockTitan
Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $9.00 - MarketBeat
Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Pyxis Oncology stock gains as Stifel says buy (NASDAQ:PYXS) - Seeking Alpha
Pyxis Oncology (NASDAQ:PYXS) Earns Buy Rating from Analysts at Stifel Nicolaus - MarketBeat
What was Pyxis Oncology Inc (PYXS)’s performance in the last session? - US Post News
Pyxis Oncology (NASDAQ:PYXS) Earns Buy Rating from Analysts at Stifel Nicolaus - Defense World
Stifel sets $10 target on Pyxis Oncology, cites unique approach - Investing.com
Market Recap Check: Pyxis Oncology Inc (PYXS)’s Positive Finish at 3.37, Up/Down 3.69 - The Dwinnex
Pyxis Oncology Insider Stock Sellers Must Be Relieved As Market Cap Falls To US$203m - Simply Wall St
Pyxis Oncology Inc (PYXS) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
SG Americas Securities LLC Makes New Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - Marketscreener.com
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - StockTitan
July Breakout: Healthcare Biotechs In The Strongest Move Since November - Seeking Alpha
Pyxis Oncology, Inc. (NASDAQ:PYXS) Short Interest Update - MarketBeat
RBC Capital remains positive on Pyxis Oncology stock - Investing.com
Is Pyxis Oncology Inc (PYXS) positioned for future growth? - SETE News
Was Pyxis Oncology Inc (PYXS)’s session last reading good? - US Post News
Pyxis Oncology Inc (PYXS) Stock: A Year of Market Fluctuations - The InvestChronicle
Pyxis Oncology Inc (PYXS) stock analysis: A comprehensive overview - US Post News
Susquehanna Fundamental Investments LLC Invests $351,000 in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $8.80 Consensus Price Target from Analysts - MarketBeat
Did Pyxis Oncology Inc (PYXS) perform well in the last session? - US Post News
Analytical Overview: Pyxis Oncology Inc (PYXS)’s Ratios Tell a Financial Story - The Dwinnex
Nothing is Better Than Pyxis Oncology Inc (PYXS) stock at the moment - SETE News
Pyxis Oncology Inc (PYXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Pyxis Oncology Inc 주식 (PYXS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Wadhane Jitendra | Chief Accounting Officer |
Sep 27 '23 |
Buy |
1.87 |
2,500 |
4,675 |
226,937 |
| Connealy Pamela Ann | CFO and COO |
Sep 27 '23 |
Buy |
1.85 |
6,426 |
11,868 |
810,532 |
| Wadhane Jitendra | Chief Accounting Officer |
Sep 25 '23 |
Buy |
1.77 |
5,000 |
8,850 |
224,437 |
| Connealy Pamela Ann | CFO and COO |
Sep 25 '23 |
Buy |
1.67 |
12,000 |
20,044 |
804,106 |
| Wadhane Jitendra | Chief Accounting Officer |
Sep 22 '23 |
Buy |
1.74 |
2,500 |
4,349 |
219,437 |
| Connealy Pamela Ann | CFO and COO |
Sep 22 '23 |
Buy |
1.74 |
5,000 |
8,695 |
792,106 |
| Sullivan Lara | President and CEO |
Sep 18 '23 |
Sale |
2.10 |
8,541 |
17,936 |
2,403,882 |
1.19%
1.65%
자본화:
|
볼륨(24시간):